Human Immunodeficiency Virus

Efficacy, Tolerability and Acceptability of Biktarvy by TPLWH

Switch to DOVATO in Patients Suppressed on Biktarvy (SOUND)

Efficacy, Safety & Tolerability of Switching EFV/TDF/FTC to BIC/FTC/TAF in Virologically Suppressed Adults With HIV-1

Impact of Hepatitis C Therapy and Bone Health

Triumeq As an Integrase Single Tablet Regimen in People With HIV Who Inject Drugs

The Tolerability of, and Adherence to, Dolutegravir With Co-formulated Tenofovir-emtricitabine for HIV Non-occupational Post-exposure Prophylaxis

HIV Non-Occupational Post-Exposure Prophylaxis

Switching Undetectables to Selzentry

Post-Exposure Prophylaxis in Health Care Workers

Raltegravir (Isentress/MK-0518) and HIV-1 Infected CD4 Cells During Acute/Early HIV-1

Efficacy Study of Different Laboratory Management Strategies and Drug Regimens in HIV-infected Children in Africa

V+PSF-M for Tobacco Cessation in HIV Care in India

Efficacy of BIC/F/TAF Versus Standard of Care in the Treatment of New HIV Infection Diagnoses in the Context of 'Test and Treat'

HIV Drug Switch Followed by HCV Therapy in HIV-HCV Co-Infection

A Study of Raltegravir in a Diverse Cohort of HIV-Infected Patients (0518-055)

Radiopaque Matrix MK-8591 Implant in Participants at Low-Risk for Human Immunodeficiency Virus Type 1 (HIV-1) Infection (MK-8591-043)

Mechanisms of Benefit of IL4RA Inhibition in Aspirin-Exacerbated Respiratory Disease

Elite Controller and ART-treated HIV+ Statin Versus ASA Treatment Intervention Study

Evaluation of Raltegravir Plus Maraviroc Therapy in Controlled HIV Patients Presenting With Lipohypertrophy

An Open Label Pharmacokinetic, Safety And Efficacy Study Of Maraviroc In Combination With Background Therapy For The Treatment Of HIV-1 Infected, CCR5 -Tropic Children

Anti-CTLA-4 Human Monoclonal Antibody CP-675,206 in Patients With Advanced Hepatocellular Carcinoma

Mentor Mothers: A Sustainable Family Intervention in South African Townships

Safety And Efficacy Study Of CP-675,206 In HIV-Infected Patients

Capravirine (AG1549) in Combination With Viracept and Two NRTIs in HIV Infected Patients Who Failed an Initial NNRTI Containing Regimen

Lenacapavir Intensification to Disrupt HIV Reservoirs in Virologically Suppressed People With HIV Receiving Antiretroviral Therapy

First in Human Study of TLC-ART 101 (ACTU 2001)

3BNC117-LS and 10-1074-LS Plus N-803 (bNAb+N-803)

MK-8527 Single-Dose Trial in HIV-1 Infected Participants (MK-8527-004)

3BNC117-LS and 10-1074-LS in Viremic HIV-infected Individuals

Pharmacokinetics of Plasma Doravirine Once Daily Over 72 Hours Following Drug Intake Cessation in Healthy Volunteers

A Study of MK-8527 in Human Immunodeficiency Type 1 Virus (HIV-1) Infected Participants (MK-8527-002)

Study of the Safety, Tolerability and Pharmacokinetics of TMB-607 in HIV-Negative Volunteers

Pharmacokinetic Study of Raltegravir in Human Immunodeficiency Virus/Hepatitis C Virus (HIV/VHC) Coinfected Patients With Advanced (Child-Pugh C) Hepatic Cirrhosis

Comparison of Concentration-time Course of Plasma and Intracellular Raltegravir in Healthy Volunteers

Interactions of Hepatitis C Viral (HCV) Dynamics and Immune Activation in HIV Coinfected Patients During HCV Treatment

Integrated Mental Health Care for Pregnant Women With HIV in Kenya: The Tunawiri Study

Data Science and Qualitative Research for Decision Support in the HIV Care Cascade

Evaluation of Problem Management Plus in Pregnant Women With HIV in Kenya

A Real-life Study of the Use of Cabotegravir Plus Rilpivirine Long-acting in ART-experienced Pre-treated People With HIV

A Savings Intervention to Reduce Men's Engagement in HIV Risk Behaviors

Simunye: A Couples-focused Intervention for HIV Prevention and Care in South Africa

Pilot Test of a Couple-Based Medication Adherence Intervention for HIV-Positive Women and Their Male Partners in South Africa

Self-Test Strategies and Linkage Incentives to Improve ART and PrEP Uptake in Men

Acceptability, Feasibility and Impact of Oral HIV Self-testing for Partner Testing Among Kenyan Adolescent Girls Aged 15-19 Years: A Randomized Controlled Trial

Linking Persons With HIV, Discharged From Jail, With Community Care

Clinical Opportunities and Management to Exploit Biktarvy as Asynchronous Connection Key (COMEBACK)

Usability Study of IeHS in Indonesia

2-5 Intermittent Caloric Restriction in HIV

Impact of Integrated HIV/NCD Screening on HIV Testing Uptake and Engagement in HIV Care in Kisarawe, Tanzania

Prevention and Treatment Continuum for Youth at HIV Risk, Acutely Infected and With Established HIV Infection